[1]管清龙,纪卫政,任伟新,等.肝癌介入治疗后血清缺氧诱导因子和血管内皮生长因子含量变化对预后的影响[J].介入放射学杂志,2014,(02):142-146.
 GUAN Qing? long,JI Wei? zheng,REN Wei? xin,et al.The influence of serum HIF?蛳 1a and VEGF content on the prognosis in patients with hepatocellular carcinoma after TACE[J].journal interventional radiology,2014,(02):142-146.
点击复制

肝癌介入治疗后血清缺氧诱导因子和血管内皮生长因子含量变化对预后的影响 ()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2014年02期
页码:
142-146
栏目:
实验研究
出版日期:
2014-02-28

文章信息/Info

Title:
The influence of serum HIF?蛳 1a and VEGF content on the prognosis in patients with hepatocellular carcinoma after TACE
作者:
 管清龙 纪卫政 任伟新 顾俊鹏
Author(s):
 GUAN Qing?蛳 long JI Wei?蛳 zheng REN Wei?蛳 xin GU Jun?蛳 peng.
 Department of Interventional Radiology, the First Affiliated Hospital of Xinjiang Medical University, Wulumuqi 830054, China
关键词:
 【关键词】 肝癌 肝动脉灌注化疗栓塞术 血管内皮生长因子 缺氧诱导因子-1a
文献标志码:
A
摘要:
 【摘要】 目的 探讨肝癌肝动脉灌注化疗栓塞术(transarterial chemoembolization,TACE)治疗后血清中缺氧诱导因子(HIF)?蛳 1a、血管内皮生长因子(VEGF)的含量变化对预后的影响。方法 2007年1月—2012年1月对60例肝癌患者行TACE治疗,另选20名正常人作为对照组,检测患者术前、术后血清HIF?蛳 1a VEGF含量。采用Cox回归模型分析KPS评分、Child?蛳 Pugh分级、门脉癌栓、血管侵犯及BCLC分期等因素对生存期的影响。采用Kanplan?蛳 Meier法分析术后血清中HIF?蛳 1a VEGF含量变化对预后的影响。结果 60例患者TACE术前HIF?蛳 1a和VEGF含量分别为(175.7 ± 62.2)pg/ml和(346.6 ± 134.6)pg/ml,明显高于对照组的(15.1 ± 5.07)pg/ml和(49.9 ± 11.2)pg/ml,差异有统计学意义(P < 0.001)。术后第1天血清HIF?蛳 1a含量明显高于术前[(603.1 ± 166.6)pg/ml比(175.7 ± 62.2)pg/ml,P < 0.01]。VEGF含量与术前相比差异无统计学意义(P > 0.05)。术后1周血清HIF?蛳 1a、VEGF含量分别为(210.7 ±61.5)pg/ml和(300.1 ± 82.6)pg/ml ,较术前明显下降(P < 0.05);术后1个月下降更明显[分别为(146.8 ± 50.6)pg/ml和(244.8 ± 54.5)pg/ml,P < 0.001)]。Cox回归分析证实KPS评分、Child?蛳 Pugh分级、门脉癌栓、肝内外转移、血管侵犯等因素中,回归系数对风险度有重要相关性。Kanplan?蛳 Meier分析显示,术后血清HIF?蛳 1a、VEGF含量高低对评估预后有指导意义。结论 肝癌患者行TACE治疗后血清HIF?蛳 1a和VEGF含量变化对预后有较大的影响。

参考文献/References:

 [1] Lewandowski RJ, Mulcahy MF, Kulik LM, et al. Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172?蛳 patient cohort[J]. Radiology, 2010, 255: 955 ?蛳 965.
[2] Bruix J, Sala M, Llovet JM. Chemoembolization for hepatocellular carcinoma[J]. Gastroenterology, 2004, 127(5 Suppl): S179 ?蛳 188.
[3] Bruix J, Sherman M. American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update[J]. Hepatology, 2011, 53: 1020 ?蛳 1022.
[4] Mathonnet M, Descottes B, Valleix D, et al. Quantitative analysis using ELISA of vascular endothelial growth factor and basic fibroblast growth factor in human colorectal Cancer, liver metastasis of colorectal Cancer and hepatocellular carcinoma[J]. World J Gastroenterol, 2006, 12: 3782 ?蛳 3783.
[5] Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxia?蛳 inducible factor 1alpha in common human cancers and their metastases[J]. Cancer Res, 1999, 59: 5830 ?蛳 5835.
[6] Cao D, Hou M, Guan YS, et al. Expression of HIF?蛳 1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications[J]. BMC Cancer, 2009, 9: 432.
[7] Ryan HE, Poloni M, McNulty W, et al. Hypoxia?蛳 inducible factor?蛳 lalpha is a positive factor in solid tumor growth[J]. Cancer Res, 2000, 60: 4010 ?蛳 4015.
[8] 黄清玲, 郑大利, 张 声, 等. 原发性肝癌中结构型一氧化氮合酶mRNA的表达及其意义[J]. 中华肿瘤杂志, 2003, 25: 250 ?蛳 254.
[9] 郑延波, 徐 克. 缺氧诱导因子-1A在兔VX2肝癌模型TACE术后的表达及其临床意义[J]. 介入放射学杂志, 2007, 16: 334 ?蛳 338.
[10] Zagzag D, Zhong HJ, Scalzitti JM, et al. Expression of hypoxia?蛳 inducible factor lalpha in brain tumors: association with angiogenesis, invasion, and progression[J]. Cancer, 2000, 88: 2606 ?蛳 2618.
[11] 肖恩华, 李锦清, 黄洁夫. 术前经动脉化疗栓塞对肝癌细胞增殖的影响[J]. 介入放射学杂志, 2004, 13: 31 ?蛳 34.
[12] Liu Y, Poon RT, Li Q, et al. Both antiangiogenesis?蛳 and angiogenesis?蛳 independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584[J]. Cancer Res, 2005, 65: 3691 ?蛳 3699.
[13] Zhao J, Hu J, Cai J, et al. Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma[J]. Chin Med J(Engl), 2003, 116: 772 ?蛳 776.
[14] Guo JH, Zhu X, Li XT, et al. Impact of serum vascular endothelial growth factor on prognosis in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization[J]. Chin J Cancer Res, 2012, 24: 36 ?蛳 43.

相似文献/References:

[1].Spontaneous regression of a giant basilar artery aneurysm in a young adult after surgical injury :case report and literature review[J].介入放射学杂志,2007,(10):718.
 ZHANG He,LI Ming-hua,WANG Chun,et al.Spontaneous regression of a giant basilar artery aneurysm in a young adult after surgical injury :case report and literature review[J].journal interventional radiology,2007,(02):718.
[2]李统怀,郑红枫. 子宫动脉栓塞治疗子宫瘢痕妊娠11例[J].介入放射学杂志,2011,(11):898.
 LI Tong-huai,ZHENG Hong-feng..Clinical application of uterine artery embolization in treating uterine scar pregnancy[J].journal interventional radiology,2011,(02):898.
[3]吕维富,张爱武,周春泽,等. 子宫动脉的三维DSA表现及其最佳显示体位探讨[J].介入放射学杂志,2011,(11):853.
 LV Wei-fu,ZHANG Ai-wu,ZHOU Chun-ze,et al.3D-DSA findings of uterine artery and its optimal projection position[J].journal interventional radiology,2011,(02):853.
[4]张 靖,周少毅,陈昆山,等.经导管动脉硬化栓塞联合注射硬化治疗婴儿颌面部巨大高流量血管瘤[J].介入放射学杂志,2011,(11):848.
 ZHANG Jing,ZHOU Shao-yi,CHEN Kun-shan,et al.Transcatheter arterial sclerosing embolization with injection sclerotherapy for the treatment of huge and high-flow maxillofacial hemangiomas in infants[J].journal interventional radiology,2011,(02):848.
[5]谢小西,吕银祥,章宏欣,等. 肝动脉化疗栓塞、射频消融联合125Ⅰ粒子植入 治疗原发性肝癌的临床应用[J].介入放射学杂志,2011,(11):863.
 XIE Xiao-xi,LV Yin-xiang,ZHANG Hong-xin,et al.The clinical application of TACE together with RFA and 125Ⅰ seed implantation in treating hepatocellular carcinoma[J].journal interventional radiology,2011,(02):863.
[6]王铭义,王 峰. 脑灌注成像在颈动脉狭窄介入治疗中的应用[J].介入放射学杂志,2011,(11):915.
 WANG Ming-yi,WANG Feng..Application of brain perfusion imaging in interventional treatment of carotid artery stenosis[J].journal interventional radiology,2011,(02):915.
[7]杜 猛,张锦生. 介入治疗急性深静脉血栓的临床观察[J].介入放射学杂志,2011,(11):858.
 DU Meng,ZHANG Jing-sheng..Interventional therapy for acute deep venous thrombosis: a clinical observation[J].journal interventional radiology,2011,(02):858.
[8]孟庆娜,李国庆,白晓冬. 急性心肌梗死介入治疗术中恶心呕吐的护理[J].介入放射学杂志,2011,(11):913.
 MENG Qing-na,LI Guo-qing,BAI Xiao-dong..The nursing care of nausea and vomiting occurred in interventional treatment for acute myocardial infarction[J].journal interventional radiology,2011,(02):913.
[9]王海亭,蒋忠仆,周 毅,等. 透视引导下鱼肝油酸钠泡沫硬化剂治疗下肢静脉曲张30例[J].介入放射学杂志,2011,(11):905.
 WANG Hai-ting,JIANG Zhong-pu,ZHOU Yi,et al.Fluoroscopically-guided foam sclerotherapy with sodium morrhuate for the treatment of lower extremity varices[J].journal interventional radiology,2011,(02):905.
[10]杜 鲲,管 生,胡小波,等. 原发性肝癌TACE术后完全缓解病灶磁共振 ADC值可重复性及一致性研究[J].介入放射学杂志,2011,(11):867.
 DU Kun,GUAN Sheng,HU Xiao-bo,et al.Magnetic resonance apparent diffusion coefficient values of the completely remitted lesions of primary hepatocellular carcinoma after TACE: a study of their repeatability and consistency[J].journal interventional radiology,2011,(02):867.
[11]张   磊,陆骊工,李   勇,等.门静脉支架联合肝动脉化疗栓塞治疗肝癌伴门静脉癌栓的临床研究[J].介入放射学杂志,2011,(12):968.
 ZHANG Lei,LU Li-gong,LI Yong,et al.Portal vein stent placement combined with TACE for the treatment of hepatocellular carcinoma associated with tumor thrombus in portal vein[J].journal interventional radiology,2011,(02):968.
[12]敖 劲,张跃伟,徐 克. 明胶海绵微粒经动脉栓塞治疗原发性肝癌的研究现状[J].介入放射学杂志,2011,(12):1010.
 AO Jin,ZHANG Yue-wei,XU Ke..Gelatin sponge particle used as an embolic agent in transcatheter arterial chemoembolization treatment for primary hepatocellular carcinoma: its current situation in research[J].journal interventional radiology,2011,(02):1010.
[13]杜丹丹,吕维富. 肝癌射频消融后的影像学评价[J].介入放射学杂志,2012,(01):75.
 DU Dan dan,Lv Wei fu..Imaging evaluation of liver cancer after radiofrequency ablation therapy[J].journal interventional radiology,2012,(02):75.
[14]赵 艳,韩国宏,白 苇,等. 药物缓释微球肝动脉化疗栓塞治疗肝癌研究进展[J].介入放射学杂志,2012,(01):78.
 ZHAO Yan,HAN Guo-hong,BAI Wei,et al.Transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma: its research progress[J].journal interventional radiology,2012,(02):78.
[15]帕哈尔丁·白克热,杨树法,黄伍奎,等.肝动脉化疗栓塞联合射频消融术治疗30例原发性大肝癌的疗效评价[J].介入放射学杂志,2012,(04):322.
 ,,et al.TACE combined with radiofrequency ablation for massive primary hepatocellular carcinomas: a clinical therapeutic evaluation [J].journal interventional radiology,2012,(02):322.
[16]杨永波,程红岩.肝动脉化疗栓塞治疗中碘油用量的现状与研究进展[J].介入放射学杂志,2012,(04):348.
 .The volume of Lipiodol used in TACE: its current situation and research progress [J].journal interventional radiology,2012,(02):348.
[17]何海涛,刘 圣,刘建秦,等. 肝癌TACE术并发脑碘油栓塞二例并文献复习[J].介入放射学杂志,2012,(08):682.
 HE Hai- tao,LIU sheng,LIU Jian- qing,et al. Cerebral Lipiodol embolism occurred after transcatheter arterial chemoembolization for hepatocellular carcinoma: report of two cases with literature review[J].journal interventional radiology,2012,(02):682.
[18]冉 琳,任伯绪. 125I粒子组织间近距离放射治疗肝癌的现状与进展[J].介入放射学杂志,2012,(10):876.
 RAN Lin,REN Bo- xu.. 125I radioactive seeds brachytherapy for hepatocellular carcinomas: its present situation and research progress[J].journal interventional radiology,2012,(02):876.
[19]罗中华,秦 勉,张学昕,等.原发性肝癌合并下腔静脉及右心房癌栓的动脉内化疗栓塞治疗[J].介入放射学杂志,2012,(12):1035.
 LUO Zhong? hua,QIN Mian,ZHANG Xue? xin,et al. Transcatheter arterial chemoembolization for hepatocellular carcinoma complicated by tumor thrombus in inferior vena cava and right atrium[J].journal interventional radiology,2012,(02):1035.
[20]徐光如,张明辉,朱红星,等.磁共振ADC值评价肝硬化合并肝癌介入治疗后肝功能储备的初步研究[J].介入放射学杂志,2013,(01):36.
 XU Guang? ru,ZHANG Ming? hui,ZHU Hong? xing,et al. The application of MR?蛳 ADC value in evaluating the liver function reserve in patients with cirrhosis complicated by hepatic cancer after interventional treatment: a preliminary study[J].journal interventional radiology,2013,(02):36.

备注/Memo

备注/Memo:
 (收稿日期:2013-06-02)
更新日期/Last Update: